Intuniv is an FDA-approved medication for treating attention deficit hyperactivity disorder (ADHD) in children and adolescents ages 6 to 17. Its active ingredient, guanfacine extended-release, is a non-stimulant, meaning it works differently from medications like Adderall or Ritalin. It can be prescribed on its own or added alongside a stimulant when that stimulant isn’t fully controlling symptoms.
How Intuniv Treats ADHD
Intuniv targets a specific type of receptor in the prefrontal cortex, the part of the brain responsible for attention, impulse control, and working memory. By activating these receptors, it strengthens the connections between nerve cells in that region, essentially helping the prefrontal cortex work more efficiently. This is particularly useful under distracting conditions, when strong prefrontal cortex function matters most.
This mechanism is fundamentally different from stimulant medications, which increase dopamine and norepinephrine levels throughout the brain. Intuniv’s more targeted approach makes it an option for children who can’t tolerate stimulants, who have conditions that stimulants could worsen (like anxiety or tics), or who need additional symptom control on top of a stimulant.
Using Intuniv Alone vs. With a Stimulant
Intuniv is approved for two distinct uses: as the sole ADHD medication (monotherapy) or as an add-on to a stimulant that isn’t doing enough on its own (adjunctive therapy). Clinical trials tested both approaches in children and teens ages 6 to 17, and both showed meaningful reductions in ADHD symptom scores compared to placebo.
As a standalone treatment, Intuniv reduced ADHD symptom scores by roughly 16 to 20 points from baseline across multiple trials, compared to about 8 to 10 points with placebo. The difference was consistent across doses ranging from 1 mg to 4 mg, with higher doses generally producing slightly larger improvements.
As an add-on, the picture is a bit different. In a trial of 455 children and adolescents who weren’t getting enough benefit from their stimulant alone, adding Intuniv improved symptom scores by about 20 to 21 points, compared to roughly 16 points for those who added a placebo to their stimulant. The gap is smaller because the stimulant was already doing part of the work, but the additional benefit was statistically significant. Both morning and evening dosing worked in this scenario.
Off-Label Uses
Prescribers sometimes use Intuniv for conditions beyond ADHD when they believe the benefits outweigh the risks. These off-label uses include tic disorders, disruptive behavior disorders, irritability associated with autism, and post-traumatic stress disorder (PTSD). The evidence supporting these uses is more limited than for ADHD, but guanfacine’s calming effect on the nervous system makes it a reasonable option in some clinical situations, particularly for children who struggle with impulsivity, hyperarousal, or aggression.
Common Side Effects
The most noticeable side effect of Intuniv is sleepiness. Because the medication calms part of the nervous system, drowsiness and fatigue are common, especially in the first few weeks. Many children adjust over time, but this is worth knowing about before starting. Taking the dose in the evening can help, since the peak drowsiness then overlaps with sleep.
Intuniv also lowers blood pressure and heart rate. For most healthy children, this drop is mild and doesn’t cause problems. But it does mean that heart rate and blood pressure should be checked before starting the medication, after any dose increase, and periodically throughout treatment. Children taking other medications that also lower blood pressure or heart rate need closer monitoring, as the effects can stack.
Other reported side effects include headache, stomach pain, nausea, and dizziness. These tend to be more common at higher doses and often improve as the body adjusts.
Starting and Stopping Intuniv
Intuniv is typically started at a low dose and increased gradually. This slow ramp-up helps minimize side effects, particularly drowsiness and blood pressure drops. The tablets come in 1 mg, 2 mg, 3 mg, and 4 mg strengths, and the right dose depends on the child’s weight and response. The extended-release formulation means it’s taken once a day.
Stopping Intuniv requires a gradual taper rather than quitting abruptly. Because the medication affects blood pressure regulation, stopping suddenly can cause a rebound increase in blood pressure and heart rate. The dose is typically reduced in small steps over several days, with blood pressure and pulse monitored along the way. This is true whether your child is taking Intuniv alone or alongside a stimulant.
Drug Interactions to Know About
Intuniv is broken down in the liver by a specific enzyme system. Medications or substances that slow down this enzyme can cause guanfacine levels to build up in the body, increasing the risk of side effects like excessive drowsiness or low blood pressure. Conversely, medications that speed up this enzyme can reduce Intuniv’s effectiveness. If your child starts or stops another medication while taking Intuniv, the prescriber may need to adjust the dose.
Medications that independently lower blood pressure or heart rate deserve particular caution when combined with Intuniv. The combined effect can increase the risk of fainting, especially when standing up quickly. This includes some heart medications, certain psychiatric drugs, and even over-the-counter cold medicines that contain ingredients affecting blood pressure.
How Intuniv Compares to Stimulants
Stimulants remain the first-line treatment for ADHD because they tend to produce larger and faster symptom improvements. Intuniv’s effects are more modest, but it fills an important role for children who experience problematic side effects from stimulants (like appetite loss, insomnia, or increased anxiety), who have co-occurring conditions like tics that stimulants can worsen, or who simply don’t respond well to stimulant medication.
One practical difference: Intuniv is not a controlled substance. Unlike stimulant ADHD medications, it carries no risk of abuse or dependence, which simplifies prescribing and refills. It also doesn’t suppress appetite or interfere with sleep the way stimulants often do. For some families, these practical advantages matter as much as the clinical data.